4//SEC Filing
Glicklich Alan 4
Accession 0001209191-21-060111
CIK 0001435049other
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 6:46 PM ET
Size
9.5 KB
Accession
0001209191-21-060111
Insider Transaction Report
Form 4
Glicklich Alan
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-10-06+7,103→ 7,103 total - Tax Payment
Common Stock
2021-10-06$12.37/sh−2,489$30,785→ 4,614 total - Exercise/Conversion
Restricted Stock Units (RSU)
2021-10-06−7,103→ 14,208 totalExp: 2030-10-05→ Common Stock (7,103 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F4]The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on October 6, 2021, until fully vested subject to the reporting person's provision of service to the Issuer on each vesting date.
Documents
Issuer
CHINOOK THERAPEUTICS, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001823197
Filing Metadata
- Form type
- 4
- Filed
- Oct 7, 8:00 PM ET
- Accepted
- Oct 8, 6:46 PM ET
- Size
- 9.5 KB